Global Complex Injectable Market Insights and Forecast to 2031

Report ID: 1665443 | Published Date: Jan 2025 | No. of Page: 95 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Complex Injectable Product Introduction
    1.2 Market by Type
        1.2.1 Global Complex Injectable Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Bottles
        1.2.3 Vials
        1.2.4 Ampules
        1.2.5 Cartridges
    1.3 Market by Application
        1.3.1 Global Complex Injectable Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals And Clinics
        1.3.3 Home Care Settings
        1.3.4 Online Pharmacies
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Complex Injectable Sales Estimates and Forecasts 2017-2028
    2.2 Global Complex Injectable Revenue Estimates and Forecasts 2017-2028
    2.3 Global Complex Injectable Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Complex Injectable Sales by Region
        2.4.1 Global Complex Injectable Sales by Region (2017-2022)
        2.4.2 Global Sales Complex Injectable by Region (2023-2028)
    2.5 Global Complex Injectable Revenue by Region
        2.5.1 Global Complex Injectable Revenue by Region (2017-2022)
        2.5.2 Global Complex Injectable Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Complex Injectable Sales by Manufacturers
        3.1.1 Global Top Complex Injectable Manufacturers by Sales (2017-2022)
        3.1.2 Global Complex Injectable Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Complex Injectable in 2021
    3.2 Global Complex Injectable Revenue by Manufacturers
        3.2.1 Global Complex Injectable Revenue by Manufacturers (2017-2022)
        3.2.2 Global Complex Injectable Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Complex Injectable Revenue in 2021
    3.3 Global Complex Injectable Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Complex Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Complex Injectable Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Complex Injectable Sales by Type
        4.1.1 Global Complex Injectable Historical Sales by Type (2017-2022)
        4.1.2 Global Complex Injectable Forecasted Sales by Type (2023-2028)
        4.1.3 Global Complex Injectable Sales Market Share by Type (2017-2028)
    4.2 Global Complex Injectable Revenue by Type
        4.2.1 Global Complex Injectable Historical Revenue by Type (2017-2022)
        4.2.2 Global Complex Injectable Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Complex Injectable Revenue Market Share by Type (2017-2028)
    4.3 Global Complex Injectable Price by Type
        4.3.1 Global Complex Injectable Price by Type (2017-2022)
        4.3.2 Global Complex Injectable Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Complex Injectable Sales by Application
        5.1.1 Global Complex Injectable Historical Sales by Application (2017-2022)
        5.1.2 Global Complex Injectable Forecasted Sales by Application (2023-2028)
        5.1.3 Global Complex Injectable Sales Market Share by Application (2017-2028)
    5.2 Global Complex Injectable Revenue by Application
        5.2.1 Global Complex Injectable Historical Revenue by Application (2017-2022)
        5.2.2 Global Complex Injectable Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Complex Injectable Revenue Market Share by Application (2017-2028)
    5.3 Global Complex Injectable Price by Application
        5.3.1 Global Complex Injectable Price by Application (2017-2022)
        5.3.2 Global Complex Injectable Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Complex Injectable Market Size by Type
        6.1.1 North America Complex Injectable Sales by Type (2017-2028)
        6.1.2 North America Complex Injectable Revenue by Type (2017-2028)
    6.2 North America Complex Injectable Market Size by Application
        6.2.1 North America Complex Injectable Sales by Application (2017-2028)
        6.2.2 North America Complex Injectable Revenue by Application (2017-2028)
    6.3 North America Complex Injectable Market Size by Country
        6.3.1 North America Complex Injectable Sales by Country (2017-2028)
        6.3.2 North America Complex Injectable Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Complex Injectable Market Size by Type
        7.1.1 Europe Complex Injectable Sales by Type (2017-2028)
        7.1.2 Europe Complex Injectable Revenue by Type (2017-2028)
    7.2 Europe Complex Injectable Market Size by Application
        7.2.1 Europe Complex Injectable Sales by Application (2017-2028)
        7.2.2 Europe Complex Injectable Revenue by Application (2017-2028)
    7.3 Europe Complex Injectable Market Size by Country
        7.3.1 Europe Complex Injectable Sales by Country (2017-2028)
        7.3.2 Europe Complex Injectable Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Complex Injectable Market Size by Type
        8.1.1 Asia Pacific Complex Injectable Sales by Type (2017-2028)
        8.1.2 Asia Pacific Complex Injectable Revenue by Type (2017-2028)
    8.2 Asia Pacific Complex Injectable Market Size by Application
        8.2.1 Asia Pacific Complex Injectable Sales by Application (2017-2028)
        8.2.2 Asia Pacific Complex Injectable Revenue by Application (2017-2028)
    8.3 Asia Pacific Complex Injectable Market Size by Region
        8.3.1 Asia Pacific Complex Injectable Sales by Region (2017-2028)
        8.3.2 Asia Pacific Complex Injectable Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Complex Injectable Market Size by Type
        9.1.1 Latin America Complex Injectable Sales by Type (2017-2028)
        9.1.2 Latin America Complex Injectable Revenue by Type (2017-2028)
    9.2 Latin America Complex Injectable Market Size by Application
        9.2.1 Latin America Complex Injectable Sales by Application (2017-2028)
        9.2.2 Latin America Complex Injectable Revenue by Application (2017-2028)
    9.3 Latin America Complex Injectable Market Size by Country
        9.3.1 Latin America Complex Injectable Sales by Country (2017-2028)
        9.3.2 Latin America Complex Injectable Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Complex Injectable Market Size by Type
        10.1.1 Middle East and Africa Complex Injectable Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Complex Injectable Revenue by Type (2017-2028)
    10.2 Middle East and Africa Complex Injectable Market Size by Application
        10.2.1 Middle East and Africa Complex Injectable Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Complex Injectable Revenue by Application (2017-2028)
    10.3 Middle East and Africa Complex Injectable Market Size by Country
        10.3.1 Middle East and Africa Complex Injectable Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Complex Injectable Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Corporation Information
        11.1.2 Eli Lilly Overview
        11.1.3 Eli Lilly Complex Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Eli Lilly Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Eli Lilly Recent Developments
    11.2 Pfizer
        11.2.1 Pfizer Corporation Information
        11.2.2 Pfizer Overview
        11.2.3 Pfizer Complex Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Pfizer Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Pfizer Recent Developments
    11.3 Teva Pharmaceutical Industries
        11.3.1 Teva Pharmaceutical Industries Corporation Information
        11.3.2 Teva Pharmaceutical Industries Overview
        11.3.3 Teva Pharmaceutical Industries Complex Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Teva Pharmaceutical Industries Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Teva Pharmaceutical Industries Recent Developments
    11.4 Hospira
        11.4.1 Hospira Corporation Information
        11.4.2 Hospira Overview
        11.4.3 Hospira Complex Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Hospira Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Hospira Recent Developments
    11.5 Hikma Pharmaceutical
        11.5.1 Hikma Pharmaceutical Corporation Information
        11.5.2 Hikma Pharmaceutical Overview
        11.5.3 Hikma Pharmaceutical Complex Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Hikma Pharmaceutical Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Hikma Pharmaceutical Recent Developments
    11.6 Johnson & Johnson Pharmaceutical
        11.6.1 Johnson & Johnson Pharmaceutical Corporation Information
        11.6.2 Johnson & Johnson Pharmaceutical Overview
        11.6.3 Johnson & Johnson Pharmaceutical Complex Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Johnson & Johnson Pharmaceutical Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Johnson & Johnson Pharmaceutical Recent Developments
    11.7 Novo Nordisk
        11.7.1 Novo Nordisk Corporation Information
        11.7.2 Novo Nordisk Overview
        11.7.3 Novo Nordisk Complex Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Novo Nordisk Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Novo Nordisk Recent Developments
    11.8 Abbvie
        11.8.1 Abbvie Corporation Information
        11.8.2 Abbvie Overview
        11.8.3 Abbvie Complex Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Abbvie Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Abbvie Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Complex Injectable Industry Chain Analysis
    12.2 Complex Injectable Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Complex Injectable Production Mode & Process
    12.4 Complex Injectable Sales and Marketing
        12.4.1 Complex Injectable Sales Channels
        12.4.2 Complex Injectable Distributors
    12.5 Complex Injectable Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Complex Injectable Industry Trends
    13.2 Complex Injectable Market Drivers
    13.3 Complex Injectable Market Challenges
    13.4 Complex Injectable Market Restraints
14 Key Findings in The Global Complex Injectable Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Complex Injectable Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Bottles
    Table 3. Major Manufacturers of Vials
    Table 4. Major Manufacturers of Ampules
    Table 5. Major Manufacturers of Cartridges
    Table 6. Global Complex Injectable Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Complex Injectable Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Complex Injectable Sales by Region (2017-2022) & (K Units)
    Table 9. Global Complex Injectable Sales Market Share by Region (2017-2022)
    Table 10. Global Complex Injectable Sales by Region (2023-2028) & (K Units)
    Table 11. Global Complex Injectable Sales Market Share by Region (2023-2028)
    Table 12. Global Complex Injectable Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Complex Injectable Revenue Market Share by Region (2017-2022)
    Table 14. Global Complex Injectable Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Complex Injectable Revenue Market Share by Region (2023-2028)
    Table 16. Global Complex Injectable Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Complex Injectable Sales Share by Manufacturers (2017-2022)
    Table 18. Global Complex Injectable Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Complex Injectable Revenue Share by Manufacturers (2017-2022)
    Table 20. Complex Injectable Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Complex Injectable Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Complex Injectable by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complex Injectable as of 2021)
    Table 23. Complex Injectable Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Complex Injectable Product Offered
    Table 25. Date of Manufacturers Enter into Complex Injectable Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Complex Injectable Sales by Type (2017-2022) & (K Units)
    Table 28. Global Complex Injectable Sales by Type (2023-2028) & (K Units)
    Table 29. Global Complex Injectable Sales Share by Type (2017-2022)
    Table 30. Global Complex Injectable Sales Share by Type (2023-2028)
    Table 31. Global Complex Injectable Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Complex Injectable Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Complex Injectable Revenue Share by Type (2017-2022)
    Table 34. Global Complex Injectable Revenue Share by Type (2023-2028)
    Table 35. Complex Injectable Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Complex Injectable Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Complex Injectable Sales by Application (2017-2022) & (K Units)
    Table 38. Global Complex Injectable Sales by Application (2023-2028) & (K Units)
    Table 39. Global Complex Injectable Sales Share by Application (2017-2022)
    Table 40. Global Complex Injectable Sales Share by Application (2023-2028)
    Table 41. Global Complex Injectable Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Complex Injectable Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Complex Injectable Revenue Share by Application (2017-2022)
    Table 44. Global Complex Injectable Revenue Share by Application (2023-2028)
    Table 45. Complex Injectable Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Complex Injectable Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Complex Injectable Sales by Type (2017-2022) & (K Units)
    Table 48. North America Complex Injectable Sales by Type (2023-2028) & (K Units)
    Table 49. North America Complex Injectable Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Complex Injectable Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Complex Injectable Sales by Application (2017-2022) & (K Units)
    Table 52. North America Complex Injectable Sales by Application (2023-2028) & (K Units)
    Table 53. North America Complex Injectable Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Complex Injectable Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Complex Injectable Sales by Country (2017-2022) & (K Units)
    Table 56. North America Complex Injectable Sales by Country (2023-2028) & (K Units)
    Table 57. North America Complex Injectable Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Complex Injectable Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Complex Injectable Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Complex Injectable Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Complex Injectable Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Complex Injectable Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Complex Injectable Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Complex Injectable Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Complex Injectable Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Complex Injectable Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Complex Injectable Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Complex Injectable Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Complex Injectable Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Complex Injectable Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Complex Injectable Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Complex Injectable Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Complex Injectable Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Complex Injectable Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Complex Injectable Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Complex Injectable Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Complex Injectable Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Complex Injectable Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Complex Injectable Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Complex Injectable Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Complex Injectable Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Complex Injectable Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Complex Injectable Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Complex Injectable Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Complex Injectable Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Complex Injectable Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Complex Injectable Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Complex Injectable Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Complex Injectable Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Complex Injectable Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Complex Injectable Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Complex Injectable Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Complex Injectable Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Complex Injectable Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Complex Injectable Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Complex Injectable Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Complex Injectable Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Complex Injectable Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Complex Injectable Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Complex Injectable Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Complex Injectable Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Complex Injectable Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Complex Injectable Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Complex Injectable Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Complex Injectable Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Complex Injectable Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Eli Lilly Corporation Information
    Table 108. Eli Lilly Description and Major Businesses
    Table 109. Eli Lilly Complex Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Eli Lilly Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Eli Lilly Recent Developments
    Table 112. Pfizer Corporation Information
    Table 113. Pfizer Description and Major Businesses
    Table 114. Pfizer Complex Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Pfizer Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Pfizer Recent Developments
    Table 117. Teva Pharmaceutical Industries Corporation Information
    Table 118. Teva Pharmaceutical Industries Description and Major Businesses
    Table 119. Teva Pharmaceutical Industries Complex Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Teva Pharmaceutical Industries Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Teva Pharmaceutical Industries Recent Developments
    Table 122. Hospira Corporation Information
    Table 123. Hospira Description and Major Businesses
    Table 124. Hospira Complex Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Hospira Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Hospira Recent Developments
    Table 127. Hikma Pharmaceutical Corporation Information
    Table 128. Hikma Pharmaceutical Description and Major Businesses
    Table 129. Hikma Pharmaceutical Complex Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Hikma Pharmaceutical Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Hikma Pharmaceutical Recent Developments
    Table 132. Johnson & Johnson Pharmaceutical Corporation Information
    Table 133. Johnson & Johnson Pharmaceutical Description and Major Businesses
    Table 134. Johnson & Johnson Pharmaceutical Complex Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Johnson & Johnson Pharmaceutical Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Johnson & Johnson Pharmaceutical Recent Developments
    Table 137. Novo Nordisk Corporation Information
    Table 138. Novo Nordisk Description and Major Businesses
    Table 139. Novo Nordisk Complex Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. Novo Nordisk Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Novo Nordisk Recent Developments
    Table 142. Abbvie Corporation Information
    Table 143. Abbvie Description and Major Businesses
    Table 144. Abbvie Complex Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. Abbvie Complex Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Abbvie Recent Developments
    Table 147. Key Raw Materials Lists
    Table 148. Raw Materials Key Suppliers Lists
    Table 149. Complex Injectable Distributors List
    Table 150. Complex Injectable Customers List
    Table 151. Complex Injectable Market Trends
    Table 152. Complex Injectable Market Drivers
    Table 153. Complex Injectable Market Challenges
    Table 154. Complex Injectable Market Restraints
    Table 155. Research Programs/Design for This Report
    Table 156. Key Data Information from Secondary Sources
    Table 157. Key Data Information from Primary Sources
List of Figures
    Figure 1. Complex Injectable Product Picture
    Figure 3. Global Complex Injectable Market Share by Type in 2021 & 2028
    Figure 3. Bottles Product Picture
    Figure 4. Vials Product Picture
    Figure 5. Ampules Product Picture
    Figure 6. Cartridges Product Picture
    Figure 7. Global Complex Injectable Market Share by Application in 2021 & 2028
    Figure 8. Hospitals And Clinics
    Figure 9. Home Care Settings
    Figure 10. Online Pharmacies
    Figure 11. Others
    Figure 12. Complex Injectable Report Years Considered
    Figure 13. Global Complex Injectable Sales 2017-2028 (K Units)
    Figure 14. Global Complex Injectable Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Complex Injectable Revenue 2017-2028 (US$ Million)
    Figure 16. Global Complex Injectable Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Complex Injectable Sales Market Share by Region (2017-2022)
    Figure 18. Global Complex Injectable Sales Market Share by Region (2023-2028)
    Figure 19. North America Complex Injectable Sales YoY (2017-2028) & (K Units)
    Figure 20. North America Complex Injectable Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Complex Injectable Sales YoY (2017-2028) & (K Units)
    Figure 22. Europe Complex Injectable Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Complex Injectable Sales YoY (2017-2028) & (K Units)
    Figure 24. Asia-Pacific Complex Injectable Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Complex Injectable Sales YoY (2017-2028) & (K Units)
    Figure 26. Latin America Complex Injectable Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Complex Injectable Sales YoY (2017-2028) & (K Units)
    Figure 28. Middle East & Africa Complex Injectable Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Complex Injectable Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Complex Injectable in the World: Market Share by Complex Injectable Revenue in 2021
    Figure 31. Global Complex Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Complex Injectable Sales Market Share by Type (2017-2028)
    Figure 33. Global Complex Injectable Revenue Market Share by Type (2017-2028)
    Figure 34. Global Complex Injectable Sales Market Share by Application (2017-2028)
    Figure 35. Global Complex Injectable Revenue Market Share by Application (2017-2028)
    Figure 36. North America Complex Injectable Sales Market Share by Type (2017-2028)
    Figure 37. North America Complex Injectable Revenue Market Share by Type (2017-2028)
    Figure 38. North America Complex Injectable Sales Market Share by Application (2017-2028)
    Figure 39. North America Complex Injectable Revenue Market Share by Application (2017-2028)
    Figure 40. North America Complex Injectable Sales Share by Country (2017-2028)
    Figure 41. North America Complex Injectable Revenue Share by Country (2017-2028)
    Figure 42. U.S. Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Complex Injectable Sales Market Share by Type (2017-2028)
    Figure 45. Europe Complex Injectable Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Complex Injectable Sales Market Share by Application (2017-2028)
    Figure 47. Europe Complex Injectable Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Complex Injectable Sales Share by Country (2017-2028)
    Figure 49. Europe Complex Injectable Revenue Share by Country (2017-2028)
    Figure 50. Germany Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 51. France Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Complex Injectable Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Complex Injectable Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Complex Injectable Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Complex Injectable Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Complex Injectable Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Complex Injectable Revenue Share by Region (2017-2028)
    Figure 61. China Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 64. India Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Complex Injectable Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Complex Injectable Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Complex Injectable Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Complex Injectable Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Complex Injectable Sales Share by Country (2017-2028)
    Figure 76. Latin America Complex Injectable Revenue Share by Country (2017-2028)
    Figure 77. Mexico Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Complex Injectable Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Complex Injectable Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Complex Injectable Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Complex Injectable Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Complex Injectable Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Complex Injectable Revenue Share by Country (2017-2028)
    Figure 86. Turkey Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Complex Injectable Revenue (2017-2028) & (US$ Million)
    Figure 89. Complex Injectable Value Chain
    Figure 90. Complex Injectable Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Pfizer
Teva Pharmaceutical Industries
Hospira
Hikma Pharmaceutical
Johnson & Johnson Pharmaceutical
Novo Nordisk
Abbvie
Frequently Asked Questions
Complex Injectable report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Complex Injectable report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Complex Injectable report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Composite Pipes

Composite Pipes market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More